We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
-5.56%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$3.29B
AUM Growth
+$640M
Cap. Flow
+$220M
Cap. Flow %
6.67%
Top 10 Hldgs %
73.26%
Holding
93
New
21
Increased
13
Reduced
25
Closed
8

Top Buys

Rank Stock Value
1
MYOV
Myovant Sciences Ltd.
MYOV
+$431M
2
KMX icon
CarMax
KMX
+$18.4M
3
MMYT icon
MakeMyTrip
MMYT
+$10.6M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.5M
5
HUNTU
Hunter Maritime Acquisition Corp. Unit
HUNTU
+$10M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$71M
2
THC icon
Tenet Healthcare
THC
+$15.3M
3
XLNX
Xilinx Inc
XLNX
+$12.9M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$11.4M
5
BRFS
BRF SA
BRFS
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 48.57%
2 Consumer Discretionary 2.87%
3 Communication Services 2.44%
4 Technology 2.2%
5 Financials 1.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIOX
1
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$932M 28.29%
9,375,000
– –
XBI icon
2
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$527M 16.01%
8,906,400
+4,124,600
+86% +$255M
MYOV
3
DELISTED
Myovant Sciences Ltd.
MYOV
$463M 14.07%
+37,231,342
New +$431M
MMYT icon
4
MakeMyTrip
MMYT
$4.67B
$47.8M 1.45%
2,220,919
+426,895
+24% +$10.6M
ABUS icon
5
Arbutus Biopharma
ABUS
$865M
$39.2M 1.19%
16,013,540
– –
INTC icon
6
Intel
INTC
$466B
$39.1M 1.19%
1,077,204
+147,200
+16% +$5.27M
IBB icon
7
iShares Biotechnology ETF
IBB
$9.31B
$35.1M 1.07%
396,435
+115,245
+41% +$10.5M
IBB icon
8
CALL
iShares Biotechnology ETF
IBB
$9.31B
$26.5M 0.81%
+300,000
New +$27.3M
NYT icon
9
New York Times
NYT
$11.6B
$25.9M 0.79%
1,949,152
-257
-0% -$3.18K
NRE
10
DELISTED
NorthStar Realty Europe Corp.
NRE
$25.5M 0.78%
2,092,501
-221,589
-10% -$2.43M
KANG
11
DELISTED
iKang Healthcare Group, Inc.
KANG
$24.3M 0.74%
1,401,640
+283,300
+25% +$4.79M
KMX icon
12
CarMax
KMX
$8.27B
$21.1M 0.64%
+327,289
New +$18.4M
CTRA
13
DELISTED
Coterra Energy
CTRA
$19.3M 0.59%
824,742
– –
EQC
14
DELISTED
Equity Commonwealth
EQC
$18.7M 0.57%
619,763
-60,237
-9% -$1.78M
GS icon
15
Goldman Sachs
GS
$313B
$18.7M 0.57%
77,938
-349,620
-82% -$71M
ATEX icon
16
Anterix
ATEX
$1.83B
$18M 0.55%
894,031
-8,568
-0.9% -$207K
AMBA icon
17
Ambarella
AMBA
$2.99B
$17.5M 0.53%
323,077
+47,200
+17% +$2.85M
AGEN
18
Agenus
AGEN
$249M
$16.9M 0.51%
208,669
+44,676
+27% +$4.39M
PYPL icon
19
PayPal
PYPL
$49.5B
$15.6M 0.47%
394,802
+50,612
+15% +$2.03M
BLK icon
20
PUT
Blackrock
BLK
$164B
$15.2M 0.46%
+40,000
New +$14.7M
NAT icon
21
PUT
Nordic American Tanker
NAT
$1.37B
$14.8M 0.45%
1,771,560
– –
XLRN
22
DELISTED
Acceleron Pharma
XLRN
$12.8M 0.39%
500,337
-136,427
-21% -$4.32M
TSM icon
23
PUT
TSMC
TSM
$2.09T
$11.5M 0.35%
400,000
– –
MRVL icon
24
Marvell Technology
MRVL
$174B
$11M 0.33%
789,576
-349,686
-31% -$4.76M
AVXS
25
DELISTED
AveXis, Inc. Common Stock
AVXS
$10.7M 0.33%
224,756
– –
1
2 3 4

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q4 2016 Portfolio in Review

As of Q4 2016, QVT Financial held 93 positions worth $3.29B, up 24% from $2.65B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

QVT Financial deployed $220M of net new capital in Q4 2016, opening 21 new positions and adding to 13 existing holdings. Its largest new stake was Myovant Sciences Ltd.: 37,231,342 shares worth $463M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 51% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Goldman Sachs, an estimated $71M trimmed.

  • QVT Financial's largest Q4 2016 buy was Myovant Sciences Ltd.: 37,231,342 shares worth $463M.
  • QVT Financial added most to MakeMyTrip in Q4 2016, an estimated $10.6M increase.
  • QVT Financial's biggest Q4 2016 reduction was Goldman Sachs, cutting an estimated $71M.
  • QVT Financial fully exited Tenet Healthcare in Q4 2016, selling an estimated $15.3M.
  • QVT Financial's ten largest holdings make up 73% of its $3.29B portfolio in Q4 2016.
  • QVT Financial opened 21 new positions and closed 8 in Q4 2016.
  • QVT Financial's portfolio value rose 24% quarter-over-quarter to $3.29B.

Based on QVT Financial's 13F filing for Q4 2016, filed 14 Feb 2017.